Category English

Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in India

An upcoming conference in Mumbai, India will look at patent laws related to the pharmaceutical and biopharma industries regionally and internationally.

CPhI's 3rd Annual Pharma IPR 2014, taking place from 26-28 February, is a targeted conference focusing on patent related matters for pharma and biopharma industry across the globe. It is intended to provide an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the pharma and biopharma companies.

The conference agenda will cover most debated subjects like: inter-partes review; one year after the implementation of the America Invents Act; reverse payments settlements cases; current implementation of the Unitary Patent System in the EU; and formulating strategies to introduce generic products in international markets.

The programme will cover patent laws of over 13 regions including the US, EU, Japan, Mexico, Canada, India, South East Asia, and Gulf Corporation Council (GCC) countries.

Click here to view the region-wise agenda.

Free download for IP-Watch Readers! Click here to view presentations from 2013!

Academics, Authors Worldwide Start 2014 Strongly Against Surveillance

More than 250 academics from around the world have signed a declaration strongly calling for a stop to surveillance of citizens' communications online by US and European authorities. And in December, more than 500 top authors joined a coalition called Writers against Mass Surveillance calling for international rules to curb wholesale surveillance.

Conclusions From Top Trademark Offices Meeting

Five top trademark offices, which call themselves the TM5, met earlier this month in Seoul, South Korea, and agreed on seminars, reports and other activities intended to improve their coordination and help fight bad practices.

Once More, US Supreme Court Will Review Software Patents

When it comes to software-related inventions, US patent law is a confused mess. So it was no surprise that, in early December, the United States Supreme Court announced it would weigh in on the matter. The court granted certiorari in Alice Corporation v. CLS Bank in order to decide when software-related inventions are patentable subject matter. But given the complicated technology and the high court’s confusing precedents in this area, many experts fear that the ruling in Alice will bring little clarity to this area of the law.

US Issues First Report On Russia’s WTO Implementation

The first annual United States report on Russia's implementation of World Trade Organization commitments since it joined the WTO last year shows that Russia has taken many steps to comply with its commitments on intellectual property rights. But the US report found some areas where Russia is lagging.